Amneal Pharmaceuticals AMRX
NASDAQ AMRX
$16.87 -0.38 (-2.20%)
At close: Sep 10, 2026 · 4:00 PM EDT

Amneal Pharmaceuticals (AMRX) Asset Utilization Ratio (2018 - 2026)

Amneal Pharmaceuticals (AMRX) posted Asset Utilization Ratio of 0.85 for Q2 2026, up 0.98% on a QoQ basis from 0.84 in Q1 2026, and up 1.38% year-over-year from 0.84 in Q2 2025.

Analysis

Amneal Pharmaceuticals (AMRX) Asset Utilization Ratio (2018 - 2026) Analysis & Trends

Amneal Pharmaceuticals has reported Asset Utilization Ratio for 9 years, with the latest figure at 0.85 in Q2 2026.

  • On a quarterly basis, Asset Utilization Ratio rose 1.38% year-over-year to 0.85 in Q2 2026; TTM through Jun 2026 was 0.85, a 1.38% increase from a year earlier, with the FY2025 full-year figure at 0.84, up 4.95% from the prior year.
  • Asset Utilization Ratio was 0.85 for Q2 2026 at Amneal Pharmaceuticals, up from 0.84 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 0.85 in Q2 2026, with the low at 0.54 in Q2 2022.
  • Average Asset Utilization Ratio over 5 years is 0.71, with a median of 0.73 recorded in 2024.
  • The sharpest annual moves came in 2024 and 2026: Asset Utilization Ratio increased 20.03% in 2024, then advanced 1.38% in 2026.
  • Over 5 years, Asset Utilization Ratio stood at 0.58 in 2022, then increased by 15.96% to 0.67 in 2023, then rose by 20.03% to 0.8 in 2024, then advanced by 3.36% to 0.83 in 2025, then grew by 2.73% to 0.85 in 2026.
  • The last three Asset Utilization Ratio figures came in at 0.85 (Q2 2026), 0.84 (Q1 2026), and 0.83 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Teva Pharmaceutical Industries 42.33 Bn 38.68 Bn 2.15 Bn 0.43
2 Viatris 19.05 Bn 18.16 Bn 1.46 Bn 0.41
3 Dr Reddys Laboratories 9.76 Bn 9.58 Bn 396.53 Mn 0.59
4 Amneal Pharmaceuticals 5.38 Bn 5.25 Bn 334.51 Mn 0.85
5 Bausch Health Companies 2.27 Bn 436.38 Mn 2.10 Bn 0.44
6 Alvotech 1.51 Bn 1.37 Bn 2.56 Mn 0.23
7 Ani Pharmaceuticals 1.51 Bn 1.15 Bn 165.89 Mn 0.67
8 Amphastar Pharmaceuticals 1.03 Bn 737.26 Mn 93.47 Mn 0.43
9 Fennec Pharmaceuticals 393.12 Mn 351.87 Mn 17.15 Mn 0.73
10 RedHill Biopharma 171.02 Mn 171.02 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.85
Mar 31, 2026 0.84
Dec 31, 2025 0.83
Sep 30, 2025 0.84
Jun 30, 2025 0.84
Mar 31, 2025 0.82
Dec 31, 2024 0.80
Sep 30, 2024 0.77
Jun 30, 2024 0.75
Mar 31, 2024 0.72
Dec 31, 2023 0.67
Sep 30, 2023 0.65
Jun 30, 2023 0.63
Mar 31, 2023 0.61
Dec 31, 2022 0.58
Sep 30, 2022 0.54
Jun 30, 2022 0.54
Mar 31, 2022 0.54
Dec 31, 2021 0.53
Sep 30, 2021 0.52